While comparative effectiveness research has become somewhat controversial in the current health reform discussions, often because it is mischaracterized, studies which indicate the value of this research continue to be reported. The goal of comparative effectiveness research is to provide objective information to patients and physicians to assist in making good judgments about treatment options. The Journal of the American Medical Association has a current article indicating the laparoscopic nerve ablation for chronic pelvic pain in women is ineffective in relieving the pain. (JAMA Article) This condition is somewhat widespread; the treatment has some risks, since it is invasive; and there are obviously additional costs associated with the treatment. The results of this study, if implemented by physicians, should both reduce health costs and limit potential risks to patients. The study is therefore a good example of the benefits of comparative effectiveness research.
An Example of the Value of Comparative Effectiveness Research
No Comments
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
September 24, 2023
Relative Spending and Utilization for Medicare Advantage Plans
Medicare Advantage plans have lower utilization and spending than does the Medicare fee-for-service program.
Commentary
September 23, 2023
Stop-loss Insurance Claims for Self-funded Employers
A report on stop-loss insurance reveals increases in number of claims and average cost of…
Commentary
September 22, 2023
Coronamonomania Lives Forever, Part 224
From far across the Pacific comes yet another set of summaries, just like the virus.